SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is trending following a strong earnings report, with many analysts raising their price targets and the community buzzing about the company's dominance in AI. Discussions revolve around whether the AI sector is in a bubble, the impact of potential US-Saudi investment, and the sustainability of Nvidia's growth.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart's trending status is fueled by strong earnings results and an increased full-year outlook, leading to community excitement. The company's decision to transfer its stock exchange listing to Nasdaq is also a hot topic. Community members are closely watching how these factors will influence the stock's performance.

Safe & Green Holdings Corp. is a design and construction services company, which engages in the provision of code engineered cargo shipping containers. It operates through the following segments: Construction, Medical, Development, and Corporate and Support. The Construction Services segment includes the manufacturing of unit SG ECHO and other modules projects. The Medical segment consists of joint venture COVID-19 laboratory operations. The Development segment focuses on real property development. The Corporate and Support segment includes general corporate expenses such as the executive office, corporate finance, accounting, audit, tax, human resources, risk management, information technology, marketing, and legal groups, corporate overhead, and other items not allocated to any of the company's other segments. The company was founded on December 29, 1993 and is headquartered in Miami, FL.

Safe & Green Holdings Corp

Safe & Green Holdings is trending due to community excitement around a potential short squeeze, with claims of high short interest and a low float driving significant volatility. Discussions center on holding above key price levels and pushing for substantial gains, drawing parallels to previous meme stock rallies. The community is actively encouraging each other to hold firm, anticipating a major move.

EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.

Exact Sciences Corp.

Exact Sciences ($EXAS) is trending amid reports of late-stage acquisition talks by Abbott Laboratories, with potential offers exceeding $100 per share, fueling bullish sentiment. The community is discussing the potential buyout price, with some anticipating a bidding war and a deal around $125+, while others are cautious, citing a potential hard retrace if talks collapse. Bullish investors are expressing optimism about the company's underpenetrated colorectal cancer screening market, recurring Cologuard revenue, fresh patent wins, and MCED pipeline.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM is trending as investors weigh potential takeover bids against concerns about shipping rates and recent earnings. Community discussions focus on the possibility of a buyout, with some speculating on potential offer prices and the board's intentions, while others express concern over the stock's recent performance and the impact of global trade dynamics.

Bath & Body Works, Inc. is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap. The company was founded by Leslie Herbert Wexner in 1963 and is headquartered in Columbus, OH.

Bath & Body Works Inc

BBWI is trending as investors assess its potential ahead of earnings, especially given recent analyst ratings and a new share repurchase program. The community is weighing mixed signals, from new product launches and a push into college campuses, against concerns around consumer spending and sector performance. Some see the stock as undervalued with a strong potential for a holiday season boost, while others express concerns about declining sales and increasing put options.

PACS Group, Inc. is a holding company, which engages in the provision of post-acute healthcare facilities, professionals, and ancillary services. It provides senior care, assisted living, and independent living options in some of the communities. The company was founded by Jason Murray and Mark Hancock in 2013 and is headquartered in Farmington, UT.

PACS Group Inc.

PACS Group is trending due to a strong Q3 update and positive after-hours movement, with investors focusing on census/occupancy trends and balance sheet flexibility. The community is actively discussing the company's revenue guidance relative to competitors and potential upside based on analyst targets and healthcare expansion. Overall, there is buzz around steady inflow, healthcare expansion buzz, and the company's regained SEC compliance.

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Nuvation Bio Inc - Ordinary Shares - Class A

Nuvation Bio ($NUVB) is trending due to positive analyst updates, including a reiterated Market Outperform rating and price target from Citizens, following strong early performance of its lung cancer drug, Ibtrozi. Community members are comparing NUVB's data favorably against competitors like Nuvalent (NUVL), particularly regarding first-line ROS1 treatment, PFS, and intracranial response rates. Bullish sentiment is further fueled by upcoming catalysts, including potential EU partnership news and data on NUV-1511.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Abbott Laboratories

ABT is trending following news of its acquisition of Exact Sciences ($EXAS) for $21 billion, a move that would significantly expand its cancer screening and diagnostics portfolio. Community discussions revolve around the potential benefits for Abbott in the oncology segment and the valuation of Exact Sciences, with some suggesting a possible bidding war. The acquisition adds a new growth vertical, positioning Abbott as a leader in the fast-growing U.S. cancer screening and precision oncology diagnostics markets.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab (RKLB) is trending due to recent back-to-back Electron launches, showcasing the company's ability to scale operations. The community is focused on the launch live streams and what this increased launch cadence signals for future growth. Investors are optimistic, citing Rocket Lab's strong YTD performance and analyst price targets, positioning RKLB as a key player in the responsive space sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

What is HC Wainwright's Forecast for Evotec FY2025 Earnings?

Evotec AG (NASDAQ:EVO - Free Report) - Stock analysts at HC Wainwright decreased their FY2025 EPS estimates for shares of Evotec in a report released on Thursday, November 6th. HC Wainwright analyst...

Evotec (NASDAQ:EVO) Trading Down 8% - Here's What Happened

Evotec (NASDAQ:EVO) Shares Down 8% - Should You Sell...

Equities Analysts Offer Predictions for Evotec Q3 Earnings

Evotec AG (NASDAQ:EVO - Free Report) - Investment analysts at HC Wainwright issued their Q3 2026 earnings per share (EPS) estimates for Evotec in a research note issued to investors on Thursday...

Evotec (NASDAQ:EVO) Shares Gap Down - Should You Sell?

Evotec (NASDAQ:EVO) Shares Gap Down - Here's Why...

ESPR Aims to Diversify With Rare Liver Disease Candidate, Stock Up

Esperion selects ESP-2001 as a preclinical candidate for primary sclerosing cholangitis, a rare liver disease, aiming to begin clinical studies in 2026.

Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions

Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in...

Halozyme Confirms Proposal to Combine with Evotec for 11.00 Per Share in an All-Cash Transaction

Halozyme Confirms Proposal to Combine with Evotec for 11.00 Per Share in an All-Cash Transaction Halozyme Confirms Proposal to Combine with Evotec for 11.00 Per Share in an All-Cash Transaction PR...

Evotec and X-Chem Collaborate to Accelerate Early-Stage Drug Discovery

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and X-Chem, leader in DNA-encoded library (DEL) technology, today announced a collaboration agreement focused...

EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS

EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS PR...

Evotec And Claris Ventures Streamline Access to Accelerate Programmes from Claris's Portfolio Companies into The Clinic

CLARIS'S PORTFOLIO COMPANIES RECEIVE EASY ACCESS TO EVOTEC'S FULL RANGE OF PRE-CLINICAL AND CLINICAL DEVELOPMENT AND MANUFACTURING CAPABILITIESAGREEMENT BUILDS ON SUCCESSFUL COLLABORATION BETWEEN...

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties. The EVT Innovate develops drug discovery projects, assets and platforms, both internally or through academic collaborations. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, and Charles Weissmann on December 8, 1993 and is headquartered in Hamburg, Germany.

Current Price	$2.99
Prev Close	$2.96
Open	$3.00
Dividend Yield	0.00%
50-Day Moving Average	$3.68
Beta	0.97
Avg. Volume	42,059.17
PE Ratio	-6.02

52-Week High	$5.37
52-Week Low	$2.84
Market Capitalization	$1.06B
EPS (Annual)	-$0.5981
Price to Book	1.13
Revenue Per Employee	$178,593.71
Enterprise Value/EBITDA	N/A

EVO
Eaton Vance Ohio Municipal Income Trust

Feed

News

Sentiment

Fundamentals

Info

Latest EVO News

EVOEaton Vance Ohio Municipal Income Trust